These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36978460)

  • 41.
    Vaitekenas A; Tai AS; Ramsay JP; Stick SM; Kicic A
    Antibiotics (Basel); 2021 Feb; 10(2):. PubMed ID: 33540528
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
    Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
    [No Abstract]   [Full Text] [Related]  

  • 44. Tradeoffs Between Evolved Phage Resistance and Antibiotic Susceptibility in a Highly Drug-Resistant Cystic Fibrosis-Derived
    Wilburn K; Matrishin CB; Choudhury A; Larsen R; Wildschutte H
    Phage (New Rochelle); 2024 Jun; 5(2):45-52. PubMed ID: 39119204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergistic Killing and Re-Sensitization of
    Engeman E; Freyberger HR; Corey BW; Ward AM; He Y; Nikolich MP; Filippov AA; Tyner SD; Jacobs AC
    Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33668899
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model.
    Bilal H; Bergen PJ; Kim TH; Chung SE; Peleg AY; Oliver A; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427301
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
    Moriarty TF; McElnay JC; Elborn JS; Tunney MM
    Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterizations of the viability and gene expression of dispersal cells from Pseudomonas aeruginosa biofilms released by alginate lyase and tobramycin.
    Daboor SM; Raudonis R; Cheng Z
    PLoS One; 2021; 16(10):e0258950. PubMed ID: 34695148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differences in biofilm formation and antimicrobial resistance of Pseudomonas aeruginosa isolated from airways of mechanically ventilated patients and cystic fibrosis patients.
    Fricks-Lima J; Hendrickson CM; Allgaier M; Zhuo H; Wiener-Kronish JP; Lynch SV; Yang K
    Int J Antimicrob Agents; 2011 Apr; 37(4):309-15. PubMed ID: 21382698
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Filamentous Bacteriophages and the Competitive Interaction between Pseudomonas aeruginosa Strains under Antibiotic Treatment: a Modeling Study.
    Pourtois JD; Kratochvil MJ; Chen Q; Haddock NL; Burgener EB; De Leo GA; Bollyky PL
    mSystems; 2021 Jun; 6(3):e0019321. PubMed ID: 34156288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli.
    Malik S; Nehra K; Rana JS
    Virus Res; 2021 Sep; 302():198496. PubMed ID: 34182014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination antibiotics against
    Kapoor P; Murphy P
    Heliyon; 2018 Mar; 4(3):e00562. PubMed ID: 29560472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions.
    Alves DR; Perez-Esteban P; Kot W; Bean JE; Arnot T; Hansen LH; Enright MC; Jenkins AT
    Microb Biotechnol; 2016 Jan; 9(1):61-74. PubMed ID: 26347362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testing.
    Holger DJ; Lev KL; Kebriaei R; Morrisette T; Shah R; Alexander J; Lehman SM; Rybak MJ
    J Appl Microbiol; 2022 Sep; 133(3):1636-1649. PubMed ID: 35652690
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial.
    Hewer SCL; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Williamson PR;
    Lancet Respir Med; 2020 Oct; 8(10):975-986. PubMed ID: 33007285
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
    Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
    Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis.
    Blumer JL; Saiman L; Konstan MW; Melnick D
    Chest; 2005 Oct; 128(4):2336-46. PubMed ID: 16236892
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Biological characteristics and genomic information of a bacteriophage against pan-drug resistant
    Qi ZY; Yang SY; Dong SW; Zhao FF; Qin JH; Xiang J
    Zhonghua Shao Shang Za Zhi; 2020 Jan; 36(1):14-23. PubMed ID: 32023713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.